Kid's Super Daily K2 22.5 mcg

product on market Liquid Carlson 🟢 Safety: 100/100
Brand: Carlson
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.03 mL Serving Size
360 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

22.5 mcg
✅ Within RDA (0.2× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.0225mg

Other Ingredients

Medium Chain Triglyceride Oil D-Alpha-Tocopherol Rosemary extract

Label Claims — Verification

❓ Nutrient
❓ All Other
❓ Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Children 4 or More Years of Age Vegetarian Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Directions: Children 4 years of age or older: take one drop daily or as directed by your healthcare professional. May be put in food or a drink.

⚠️ Warnings & Precautions

Warning: Vitamin K can antagonize the effect of anticoagulants, including Warfarin. Do not take this product if you are taking Warfarin or are pregnant or breastfeeding without first consulting with your physician.

🧪 Formulation Notes

IGEN Non-GMO tested

Supports and promotes: Bone health Healthy blood Calcium assimilation Cardiovascular support Healthy development

Liquid Vitamin K

Vitamin K2 as MK-7 is one of the most important nutrients for developing healthy bones and helping to maintain children's strength long-term. Super Daily K2, derived from chickpeas, provides the most bioactive form of vitamin K2 in a single concentrated drop.

Gluten-free No artificial preservatives

Vegetarian

AN FDA Regulated Facility

Additional Information

IGEN Non-GMO tested

SFI Sustainable Forestry Initiative Certified Sourcing www.sfiprogram.org SFI-03531

Product Details

DSLD Entry Date 2025-08-22
Product Type Vitamin
Form Liquid
Brand Carlson
DSLD ID 337604
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI
View all evidence for Vitamin K →

Compare Similar Products

Bio-K-Mulsion Biotics Research Corporation 100
Super Daily K2 45 mcg Carlson 100
Vitamin K2 Thorne 100
Ultimate K2 Pure TheraPro Rx 100
Kid's Super Daily K2 22.5 mcg Carlson 100
View all Vitamin K products →
Vitamin K research & evidence Best Vitamin K rankings All Vitamin K products More from Carlson View on NIH DSLD →